Efficacy of high dose interferon - Alpha treatment ofchronic hepatitis B

Journal of the Medical Association of Thailand

Volumn 82, Issue 11, 1999, Pages 1118-1125

  Techapaitoon, Satien ^a  

^a RAJAVITHI HOSPITAL   (Thailand)

Author keywords

Chronic Hepatitis B; Interferon Alpha; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANOREXIA; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; HEPATITIS B; HUMAN; IMMUNOTHERAPY; LIVER HISTOLOGY; MALE; NAUSEA; THAILAND; VIRUS LOAD; WEIGHT REDUCTION;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033492852     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Chainuvati T. Viral hepatitis in Thailand. Med Prog 1994 ; Dec : 5-9.
2. Pare P. The clinical consequences of chronic hepatitis B. Hepatitis Update : 1996 ; Aug : 1-4.
3. Wong JB, Koff RS, Tine F, Pauker SG. Cost-effectiveness of interferon-alfa 2B treatment for hepatitis-B e antigen-positive chronic hepatitis B. Ann Intern Med 1995 ; 112 : 664-75.
4. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma - epidemiologic considerations. Hepatology 1982 ; 2 : 21S-26S.
5. Beasley RP. Hepatitis B Virus. The major etiology of hepatocellular carcinoma. Cancer 1988 ; 61 : 1942-56.
6. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B - related sequelae. Arch Intern Med 1990 ; 150 : 1051-4.
7. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997 ; 336 : 347-56.
8. Wong DKH, Cheung AM, O' Rourke K, Nayler CD, Detsky AS, Heathcote J. Effect of alpha - interferon treatment in patients with hepatitis B e antigen - positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993 ; 115 : 312-23.
9. Lok ASF, Wu PC, Lai CL, et al. A controlled trial of interferon with and without prednisolone priming for chronic hepatitis B. Gastroenterology 1992 ; 102 : 2091-7.
10. Malaguarnera M, Restuccia S, Receputo G, Giugno I, Pistone G, Trovato BA. The efficacy of interferon alfa in chronic hepatitis B : A review and meta-analysis. Curr Ther Res 1996 ; 57 : 646-62.
11. Sherlock S. VI International Symposium on Viral Hepatitis : Summary. Hepatology 1995 ; 22 (suppl 1) : 160-4.
12. st International Symposium on Hepatology and Clinical Pharmacology Liver and Drugs : 1994 : 17.
13. Ovartlarnporn B. Clinical experiences in management of CHBV with alpha-interferons in Thai patients (Abstract). Satellite Symposium on Management of Chronic Hepatitis B and C with Alpha Interferons. Royal college of Physicians of Thailand Meeting on April 20, 1995 at Pattaya, Thailand.
14. Hongsirinirachon M, Piyanirun W, Surangsrirut S, Churnratanakul S, Chutaputti A. A Retrospective analysis of the efficacy of interferon alfa treatment of chronic hepatitis B in Pramongkutklao Hospital (Abstract). In : International Symposium on viral hepatitis and perspectives from the Asean Region. Syllabus and Abstracts 1997 : 66.
15. Niederau C, Heintges T, Lange S, et al. Long -term follow-up of HbeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334: 1422-7.
16. Lok A. Treatment of chronic hepatitis B : Guidelines for Asian patients. In : advances in the management of chronic hepatitis B and C. Hong Kong : Medimedia Asia, 1996: 1-5.